NCT03475784

Brief Summary

Postdural puncture headache (PDPH) is a common complication after cesarean delivery (CD). The role of peri-operative fluid therapy in prophylaxis against PDPH is unclear. The aim of this work is to compare restrictive versus liberal fluid therapy in prophylaxis against PDPH after CD

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P25-P50 for phase_3

Timeline
Completed

Started Mar 2018

Shorter than P25 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 17, 2018

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 23, 2018

Completed
7 days until next milestone

Study Start

First participant enrolled

March 30, 2018

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2018

Completed
3 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 2, 2018

Completed
Last Updated

August 20, 2019

Status Verified

August 1, 2019

Enrollment Period

7 months

First QC Date

March 17, 2018

Last Update Submit

August 18, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Incidence of post-dural puncture headache

    the number of patients who develop post-dural puncture headache defined as pain scale above 4

    48 hours

Secondary Outcomes (4)

  • incidence of post-spinal hypotension

    60 minutes

  • Wong-Baker faces pain scale

    48 hours

  • heart rate

    24 hours

  • postoperative nausea and vomiting

    24 hours

Study Arms (2)

Restricted fluid therapy group

EXPERIMENTAL

Restrictive fluid therapy: this group will not receive fluid pre-load, and will receive intraoperative crystalloids at rate of 10 mL/Kg/hour followed by postoperative crystalloids at rate of 2mL/Kg/hour.

Drug: Restrictive fluid therapy

Liberal fluid therapy group

ACTIVE COMPARATOR

Liberal fluid therapy: this group will receive fluid pre-load (5 mL/Kg), and will receive intraoperative crystalloids at rate of 10 mL/Kg/hour followed by postoperative crystalloids at rate of 6 mL/Kg/hour.

Drug: Liberal fluid therapy

Interventions

This group will receive intraoperative crystalloids at rate of 10 mL/Kg/hour followed by postoperative crystalloids at rate of 2 mL/Kg/hour.

Also known as: Restrictive fluids
Restricted fluid therapy group

This group will receive crystalloid preload of 5 mL/Kg, then will receive intraoperative crystalloids at rate of 10 mL/Kg/hour followed by postoperative crystalloids at rate of 6 mL/Kg/hour.

Also known as: Liberal fluids
Liberal fluid therapy group

Eligibility Criteria

Age18 Years - 40 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Full term
  • Pregnant female
  • Scheduled to elective cesarean delivery

You may not qualify if:

  • History of migraine headache
  • Hypertensive disorders of pregnancy
  • Cardiac morbidities,
  • Baseline systolic blood pressure \< 100 mmHg
  • Contraindication of regional anesthesia.
  • Patients with more than one single attempt for spinal block

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cairo University

Cairo, Egypt

Location

MeSH Terms

Conditions

Post-Dural Puncture Headache

Condition Hierarchy (Ancestors)

Headache Disorders, SecondaryHeadache DisordersBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Tarek Abdelbarr, Professor

    Head of obstetric anesthesia section in anesthesia department

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor

Study Record Dates

First Submitted

March 17, 2018

First Posted

March 23, 2018

Study Start

March 30, 2018

Primary Completion

October 30, 2018

Study Completion

November 2, 2018

Last Updated

August 20, 2019

Record last verified: 2019-08

Data Sharing

IPD Sharing
Will not share

Locations